Chemours (CC) PT Raised to $36 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $27.03 -0.18%
Rating Summary:
7 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
7 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan raised the price target on Chemours (NYSE: CC) to $36.00 (from $33.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Comcast Corp (CMCSA) PT Lowered to $48 at Pivotal Research
- Macquarie Upgrades ASM Pacific Technology (522:HK) (ASMVY) to Outperform
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
